The case for secondary hormonal therapies in the chemotherapy age.
about
Abiraterone in the treatment of metastatic castration-resistant prostate cancerPhase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.Redefining hormone resistance in prostate cancer.Treatment patterns and characteristics of European patients with castration-resistant prostate cancer.Abiraterone acetate: a promising drug for the treatment of castration-resistant prostate cancer.Leuprorelin depot injection: patient considerations in the management of prostatic cancerMaintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implicationsAndrogen receptor: role and novel therapeutic prospects in prostate cancer.Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer.Current treatment strategies for castration-resistant prostate cancerSteroid hormone synthetic pathways in prostate cancer.Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer.
P2860
Q26853635-4F30C4B4-8F15-4BDC-BC85-A7BFAC796852Q33770362-418E26F1-DD83-42AD-834E-88C13A57847AQ33903836-051CDC37-65B6-4871-815C-E87A790CFFFCQ34481621-6B3AE798-83AC-43AA-8800-312E9AE3D5D1Q34619574-93CBAE85-C396-4153-983C-6908043FD632Q36823588-88B2BEA0-B7B6-4794-BC27-7500A57B409BQ36876865-95F972E6-D2F6-4D15-B43B-9E9AA565712CQ37159878-0964CB5A-6F90-467A-9242-89F8C334113EQ37256846-EE09247C-B568-4740-A6AB-3392DBF47267Q37564765-17794C99-B929-4168-A6CC-4111866E620BQ37860950-3556CEAF-3AAF-4BD8-BB44-EF8576EF7A7FQ38266059-5080910D-5FE8-4C59-87C2-A44333CC84B1Q41886996-F12B7A58-E001-4DB6-B663-E58FFCC4045A
P2860
The case for secondary hormonal therapies in the chemotherapy age.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The case for secondary hormonal therapies in the chemotherapy age.
@ast
The case for secondary hormonal therapies in the chemotherapy age.
@en
type
label
The case for secondary hormonal therapies in the chemotherapy age.
@ast
The case for secondary hormonal therapies in the chemotherapy age.
@en
prefLabel
The case for secondary hormonal therapies in the chemotherapy age.
@ast
The case for secondary hormonal therapies in the chemotherapy age.
@en
P1476
The case for secondary hormonal therapies in the chemotherapy age.
@en
P2093
Charles J Ryan
Eric J Small
P304
P356
10.1016/J.JURO.2006.06.071
P407
P433
P577
2006-12-01T00:00:00Z